The 103I variant of the melanocortin 4 receptor is associated with low serum triglyceride levels

被引:25
作者
Brönner, G
Sattler, AM
Hinney, A
Soufi, M
Geller, F
Schäfer, H
Maisch, B
Hebebrand, J
Schaefer, JR
机构
[1] Univ Duisburg Gesamthsch, Dept Child & Adolescent Psychiat & Psychotherapy, D-45147 Essen, Germany
[2] Univ Marburg, Inst Med Biometry & Epidemiol, D-35037 Marburg, Germany
[3] Univ Marburg, Dept Internal Med & Cardiol, D-35037 Marburg, Germany
[4] deCODE Genet, Reykjavik, Iceland
关键词
D O I
10.1210/jc.2005-0919
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: The melanocortin 4 receptor (MC4R) is an essential regulator of energy intake and body weight. Recently, the V103I polymorphism of MC4R has been shown to be negatively associated with body mass index. This suggests that serum lipids and blood pressure in individuals carrying the 103I allele might be influenced as well. Objective: The objective of this study was to determine whether the most common polymorphism of the MC4R, V103I, affects serum lipid levels and/or blood pressure. Design, Setting, and Participants: The study participants were 1173 consecutive patients undergoing cardiac catheterization; they were genotyped for the rs2229616 G -> A substitution at codon 103 (V103I polymorphism) of the MC4R gene. Patients had strictly fasted for at least 12 h before blood samples were drawn. The average age of the patients was 60.9 yr; 72% were males. Results: Heterozygous carriers of the 103I allele had significantly lower triglyceride levels than individuals homozygous for the wildtype allele (127 vs. 168 mg/dl mean total triglyceride; P = 0.001 or 0.009 after Bonferroni adjustment for seven tests). No homozygous carriers of the 103I allele were present in the study population. Conclusions: Our study suggests an influence of MC4R activity on triglyceride levels in cardiovascular patients.
引用
收藏
页码:535 / 538
页数:4
相关论文
共 27 条
[21]   The VaI103IIe polymorphism of melanocortin-4 receptor regulates energy expenditure and weight gain [J].
Rutanen, J ;
Pihlajamäki, J ;
Karhapää, P ;
Vauhkonen, I ;
Kuusisto, J ;
Mykkänen, LM ;
Laakso, M .
OBESITY RESEARCH, 2004, 12 (07) :1060-1066
[22]   Strategies to optimize CAD prevention in modern cardiology - The "Marburg CAD Prevention Project" [J].
Schaefer, JR ;
Simon, B ;
Soufi, M ;
Sattler, A ;
Noll, B ;
Herzum, M ;
Maisch, B .
HERZ, 2000, 25 (02) :113-116
[23]   LIDDLES SYNDROME - HERITABLE HUMAN HYPERTENSION CAUSED BY MUTATIONS IN THE BETA-SUBUNIT OF THE EPITHELIAL SODIUM-CHANNEL [J].
SHIMKETS, RA ;
WARNOCK, DG ;
BOSITIS, CM ;
NELSONWILLIAMS, C ;
HANSSON, JH ;
SCHAMBELAN, M ;
GILL, JR ;
ULICK, S ;
MILORA, RV ;
FINDLING, JW ;
CANESSA, CM ;
ROSSIER, BC ;
LIFTON, RP .
CELL, 1994, 79 (03) :407-414
[24]   Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity [J].
Solymoss, BC ;
Bourassa, MG ;
Campeau, L ;
Sniderman, A ;
Marcil, M ;
Lespérance, J ;
Lévesque, S ;
Varga, S .
AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (02) :159-164
[25]   Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity [J].
Vaisse, C ;
Clement, K ;
Durand, E ;
Hercberg, S ;
Guy-Grand, B ;
Froguel, P .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (02) :253-262
[26]   Identification and characterization of melanocortin-4 receptor gene mutations in morbidly obese Finnish children and adults [J].
Valli-Jaakola, K ;
Lipsanen-Nyman, M ;
Oksanen, L ;
Hollenberg, AN ;
Kontula, K ;
Bjorbæk, C ;
Schalin-Jäntti, C .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (02) :940-945
[27]   Reversal of cancer anorexia by blockade of central melanocortin receptors in rats [J].
Wisse, BE ;
Frayo, RS ;
Schwartz, MW ;
Cummings, DE .
ENDOCRINOLOGY, 2001, 142 (08) :3292-3301